Quadrant Capital Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 802 shares of ARWR stock, worth $17,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares

802

Previous 410 95.61%

Holding current value

$17,170

Previous $10,000 50.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.36 - $29.54 $7,589 - $11,579	392 Added 95.61%	802 $15,000
Q2 2024 Aug 12, 2024	BUY	$21.87 - $28.24 $3,236 - $4,179	148 Added 56.49%	410 $10,000
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $625 - $908	23 Added 9.62%	262 $7,000
Q4 2023 Feb 08, 2024	SELL	$21.2 - $31.03 $3,625 - $5,306	-171 Reduced 41.71%	239 $7,000
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $8,986 - $12,375	-343 Reduced 45.55%	410 $11,000
Q2 2023 Aug 09, 2023	SELL	$25.16 - $41.38 $2,490 - $4,096	-99 Reduced 11.62%	753 $26,000
Q1 2023 May 11, 2023	SELL	$23.68 - $38.51 $3,078 - $5,006	-130 Reduced 13.24%	852 $21,000
Q4 2022 Feb 10, 2023	BUY	$28.0 - $40.56 $14,140 - $20,482	505 Added 105.87%	982 $39,000
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $8,148 - $13,285	275 Added 136.14%	477 $16,000
Q2 2022 Aug 09, 2022	SELL	$27.79 - $50.61 $333 - $607	-12 Reduced 5.61%	202 $7,000
Q1 2022 May 06, 2022	SELL	$39.62 - $69.97 $9,350 - $16,512	-236 Reduced 52.44%	214 $10,000
Q4 2021 Feb 01, 2022	BUY	$58.09 - $82.51 $8,306 - $11,798	143 Added 46.58%	450 $30,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $525 - $764	9 Added 3.02%	307 $19,000
Q2 2021 Aug 09, 2021	SELL	$62.15 - $90.32 $7,085 - $10,296	-114 Reduced 27.67%	298 $25,000
Q1 2021 May 12, 2021	BUY	$61.35 - $90.47 $490 - $723	8 Added 1.98%	412 $27,000
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $6,573 - $12,805	150 Added 59.06%	404 $31,000
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $797 - $1,230	24 Added 10.43%	254 $11,000
Q2 2020 Aug 13, 2020	BUY	$26.12 - $43.27 $4,884 - $8,091	187 Added 434.88%	230 $10,000
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $6,805 - $20,892	-331 Reduced 88.5%	43 $1,000
Q4 2019 Feb 03, 2020	BUY	$28.14 - $73.01 $7,513 - $19,493	267 Added 249.53%	374 $21,000
Q3 2019 Oct 24, 2019	BUY	$26.26 - $34.86 $1,339 - $1,777	51 Added 91.07%	107 $2,000
Q2 2019 Jul 24, 2019	BUY	$17.43 - $28.82 $976 - $1,613	56 New	56 $1,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

91.2M

Call Options Held

130K

Put Options Held

401K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.27B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History